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ㅋ
We have focused on understanding the onset of gastroesophageal reflux disease by examining the mucosal response to the 
presence of acid in the esophageal lumen. Upon exposure to HCl, inflammation of the esophagus begins with activation of 
the transient receptor potential channel vanilloid subfamily member-1 (TRPV1) in the mucosa, and production of IL-8, sub-
stance P (SP), calcitonin gene related peptide (CGRP) and platelet activating factor (PAF). Production of SP and CGRP, but not 
PAF, is abolished by the neural blocker tetrodotoxin suggesting that SP and CGRP are neurally released and that PAF arises 
from non neural pathways. Epithelial cells contain TRPV1 receptor mRNA and protein and respond to HCl and to the TRPV1 
agonist capsaicin with production of PAF. PAF, SP and IL-8 act as chemokines, inducing migration of peripheral blood 
leukocytes. PAF and SP activate peripheral blood leukocytes inducing the production of H2O2. In circular muscle, PAF causes 
production of IL-6, and IL-6 causes production of additional H2O2, through activation of reduced nicotinamide adenine dinu-
cleotide phosphate (NADPH) oxidases. Among these, NADPH oxidase 5 cDNA is significantly up-regulated by exposure to PAF; 
H2O2 content of esophageal and lower esophageal sphincter circular muscle is elevated in human esophagitis, causing dysfunc-
tion of esophageal circular muscle contraction and reduction in esophageal sphincter tone. Thus esophageal keratinocytes, that 
constitute the first barrier to the refluxate, may also serve as the initiating cell type in esophageal inflammation, secreting in-
flammatory mediators and pro-inflammatory cytokines and affecting leukocyte recruitment and activity. 
(J Neurogastroenterol Motil 2010;16:374-388)
Key Words
Cytokines; Gastroesophageal reflux disease; Platelet activating factor; Substance P; TRPV1
Received: July 24, 2010 Revised: August 18, 2010 Accepted: August 21, 2010
CC This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons. 
org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work 
is properly cited.
*Correspondence: Piero Biancani, PhD
Department of Medicine, Rhode Island Hospital and Brown University, Claverick St, Providence, RI 02903, USA
Tel: +1-401-884-2965, Fax: +1-401-444-5890, E-mail: piero_biancani@hotmail.com
Financial support: This study was supported by NIH grant RO1 DK57030.
Conflicts of interest: None.
Introduction
Gastroesophageal reflux disease (GERD) is a common clin-
ical condition, with approximately 20% of the adult Western pop-
ulation complaining of symptoms at least once per week.
1-3 The 
pathophysiology of mucosal injury in GERD remains to be eluci-
dated, but prolonged contact of mucosa with acid contributes to 
the reflux injury. Several publications have summarized the cur-
rent understanding of the pathophysiology of GERD, but work 
on mechanisms of disease has focused primarily on damage to the 
tight junctions and loss of epithelial integrity in response to 
acid.
4,5
It was thought that esophagitis may develop from a chemical 
injury starting at the luminal surface of the squamous epithelium, 
progressing through epithelium and lamina propria into the sub-Inflammatory Mediators in Esophageal Mucosa
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Figure 1. We produced an in vitro model of esophageal inflamma-
tion using an esophageal mucosa tube tied at both ends. The tube was 
created by removing the muscle layers from the esophagus by sharp 
dissection at the interface between submucosa and circular mucle. It 
has the squamous epithelium on the inside and the whole submucosa 
on the outside. HCl or Krebs buffer was injected inside the tube, 
which was then kept in oxygenated Krebs buffer at 36
oC for 3 hours 
(1 mL Krebs buffer/100 mg mucosa). After 3 hours the supernatant 
outside the tube was collected and analyzed or used to incubate cir-
cular muscle strips. Adapted from Cheng et al.
9
mucosa, resulting in acid-induced death of surface cells, and 
stimulation of a proliferative response in the basal cells.
6 This 
view has recently been challenged; a description of the pathoge-
netic process has been provided,
7 proposing that refluxed gastric 
juice does not directly damage the esophageal mucosa, but rather 
stimulates esophageal epithelial cells to secrete chemokines. 
These in turn attract and activate immune cells that damage  the 
mature esophageal squamous epithelial cells
7 similar to other im-
mune processes of the gastrointestinal tract such as celiac disease 
where activated lymphocytes damage the mature villous cells. 
These data are also consistent with previous studies reporting that 
in experimental esophagitis in animals and in human reflux 
esophagitis pro-inflammatory cytokine production may underlie 
the development of erosive esophagitis,
8-12 which is defined by the 
infiltration of neutrophils and eosinophils into the mucosa. In ad-
dition, in an animal model of acute esophagitis, Paterson et al
13 
showed that acid perfusion caused release of platelet activating 
factor (PAF) from esophageal mucosa into the lumen and in-
duced significant epithelial injury, prevented by a PAF-anta-
gonist. The data suggest that production of cytokines or chemo-
kines and inflammatory mediators may originate in the mucosa 
and initiate the inflammatory process.
Except for one recent review,
14 however, surprisingly little 
information is available about esophageal inflammation in 
GERD even though changes at the molecular level may occur 
prior to macroscopic signs of inflammation. In the following we 
will examine interaction of acid and esophageal mucosa, leading 
to production of cytokines and inflammatory mediators, as key 
events in the onset of esophageal inflammation.
Initial Events in GERD Pathophysiology
1. TRPV1 and acid sensors
In many inflammatory processes in several organ systems the 
initial cause of the inflammation is unknown. In esophagitis a 
likely cause is gastroesophageal reflux, containing HCl, enzymes 
and bile acids. In this review the effect of one of the components 
of gastric juice, HCl, has been examined, focusing on the mecha-
nisms of its contribution to inflammation in normal esophageal 
squamous epithelium.
The squamous epithelial cells of the esophagus may respond 
to the presence of acid in its lumen through a variety of acid-sens-
ing receptors. The transient receptor potential channel, vanilloid 
subfamily member-1 (TRPV1, also known as VR1), was origi-
nally described in primary sensory neurons as a receptor for cap-
saicin and related natural irritants (collectively referred to as va-
nilloids).
15 TRPV1 is a non-selective cation channel expressed by 
sensory nerves. It is activated by heat, by the pungent ingredient 
of chili peppers, capsaicin, or by endogenous hydrogen ions re-
leased in tissues during inflammation
15 or present in gastro-
esophageal reflux. TRPV1 is now believed to function as a mo-
lecular integrator of noxious stimuli, including acids, heat, pollu-
tants with negative electric charge and endogenous pro-in-
flammatory substances.
16 Up-regulated TRPV1 expression has 
been demonstrated in disease states of the gastrointestinal tract 
such as inflammatory bowel disease,
17 irritable bowel syndrome
18 
and, more recently, esophagitis.
19,20 TRPV1 activation in primary 
afferent neurons evokes the sensation of burning pain and in-
duces neurogenic inflammation by the release of substance P 
(SP) and calcitonin-gene-related peptide (CGRP).
17,21  
2. TRPV1 and  inflammation
TRPV1-induced “neurogenic inflammation” has been exam-
ined in several systems, particularly in the airways, and to a lesser Karen M Harnett, et al
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Figure 2. When in vitro mucosa is exposed to HCl for 3 hours, substance P levels increase 6-fold in the mucosa (A) and in the supernatant (B) 
when compared to control (pH 7.4) (*p < 0.05, ANOVA). The HCl-induced increase in substance P is abolished by the transient receptor 
potential channel vanilloid subfamily member-1 receptor antagonist 5’-iodoresinferratoxin (IRTX) and by the neural blocker tetrodotoxin (TTX) 
both in the mucosa and in the supernatant (**p < 0.05, ANOVA). Bars represent mean ± SEM of 3 experiments. Adapted from Cheng et al.
72
Figure 3. When in vitro mucosa is exposed to HCl for 3 hours, calcitonin gene related peptide (CGRP) levels increase 200-fold in the mucosa (A) 
and 10-fold in the supernatant (B) when compared to control (pH 7.4) (*p < 0.05, ANOVA). The HCl-induced increase in CGRP is abolished 
by the transient receptor potential channel vanilloid subfamily member-1 receptor antagonist 5’-iodoresinferratoxin (IRTX) and by the neural 
blocker tetrodotoxin (TTX) both in the mucosa and in the supernatant (**p < 0.05, ANOVA). Bars represent mean ± SEM of 3 experiments. 
Adapted from Cheng et al.
72
extent in the digestive tract. In the digestive tract most pub-
lications have focused on the role of vanilloid receptor in in-
flammation, with emphasis on stimulation of SP release,
22-31 or on 
a role of endopeptidases in degradation of SP, with a resulting de-
crease in inflammation.
32-34 In the ileum and colon, TRPV1 is 
thought to be a mediator of inflammation because, in ex-
perimental models of colitis induced by dextran sulphate so-
dium,
35,36 or of ileitis induced by Clostridium difficile toxin A28 or 
anandamide,
27 inflammation is attenuated in response to TRPV1 
channel blockers
35,36 or after genetic deletion of TRPV1.
37
To test whether this acid-sensitive receptor may be the initial 
mediator of acid-induced inflammation in the cat esophagus, a 
tubular segment of normal esophageal mucosa and submucosa 
was removed and tied at both ends to form a mucosal sac (Fig. 
1).
9 The sac was filled with 0.01 N HCl (or normal Krebs buffer 
as controls) and kept in oxygenated Krebs buffer at 37
oC. The 
medium around the HCl-filled sac (supernatant) was collected 
after 3 hour incubation and examined for content of inflammatory Inflammatory Mediators in Esophageal Mucosa
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Figure 4. Histological sections of cat esophagus immunostained to detect (A, B) calcitonin gene related peptide (CGRP) or (C, D) Substance P. 
Immunoreactivity was detected with secondary antibody tagged with horseradish peroxidase (HRP)-conjugated polymer and diaminobenzidine 
(brown precipitate). Sections were counterstained with Hematoxylin (blue) to depict unlabeled cells. CGRP immunoreactivity was localized in 
ganglion cells (note nucleoli). Immunoreactivity was low-level and distributed throughout the cytoplasm (arrows) in the submucous plexus, although 
occasional cells had intense levels of CGRP immunoreactivity (B, double-headed arrow). Substance P immunoreactivity was easily detected in small 
neurons and fibers scattered throughout the submucous plexus. In addition fine substance P-immunoreactive fibrils were distributed in the 
submucosa, but occasional longer and somewhat tortuous fibers (probably axons) were identified (B, double-headed arrow). Adapted from Cheng 
et al.
72
mediators.
3. Substance P and calcitonin-gene-related peptide
SP and CGRP levels increased in mucosal tissue and in su-
pernatant in response to HCl (Fig. 2 and 3) and the increases 
were abolished by the TRPV1 receptor antagonist 5’-iodoresin-
ferratoxin (IRTX) or by neural block with tetrodotoxin, suggest-
ing that TRPV1-induced production of SP and CGRP was neu-
rally mediated. Increased levels of neurotransmitters in both mu-
cosa and supernatant imply de novo production of both CGRP 
and SP, requiring the presence of neural cell bodies in the sac.
In histological sections of esophagus, CGRP immunor-
eactivity is present in ganglion cells of the myenteric and sub-
mucosal plexus, with varying degrees of expression. SP im-
munoreactivity is detectable in small neurons and fibers, mainly 
scattered throughout the submucosal plexus. In addition fine 
SP-positive fibrils are distributed throughout the submucosa 
with occasional organization into longer and somewhat tortuous 
fibers (possibly axons) (Fig. 4). 
4. Platelet activating factor 
PAF is an important chemoattractant and activator of im-Karen M Harnett, et al
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Figure 5. When in vitro mucosa is exposed to HCl for 3 hours, platelet activating factor (PAF) levels increase 4-5 fold in the mucosa (A) and in 
the supernatant (B) when compared to control (pH 7.4) (*p < 0.05, ANOVA). The HCl-induced increase in PAF is abolished by the transient 
receptor potential channel vanilloid subfamily member-1 receptor antagonist 5’-iodoresinferratoxin (IRTX) (**p < 0.05, ANOVA) and not 
affected by the neural blocker tetrodotoxin (TTX) both in the mucosa and in the supernatant indicating that production of PAF arises from non 
neural tissues. Bars represent mean ± SEM of 3 experiments. Adapted from Cheng et al.
72
Figure 6. (A) To demonstrate the presence of the transient receptor 
potential channel vanilloid subfamily member-1 (TRPV1) receptor 
mRNA in non-neural cells, esophageal epithelial cells were 
enzymatically isolated and sorted by flow cytometry. Primers were 
derived from conserved regions of mRNA sequences of humans, rat, 
dog, mouse guinea pig and rabbit. The BLAST database confirmed 
that the primers were specific for TRPV1. The band produced using 
these primers was sequenced, obtaining the sequence of cat TRPV1 
with 95% homology to human TRPV1. Reverse transcriptase- 
polymerase chain reaction (RT-PCR) confirmed the presence of 
TRPV1 receptor mRNA in these cat esophageal epithelial cells. (B) 
To perform a Western blot analysis, the epithelial cells were 
immunoprecipitated with an epithelial cell selective pan-cytokeratin 
antibody conjugated with magnetic beads and were isolated by 
exposing the suspension to a magnetic field as specified by the 
manufacturer. A 150 kDa band was immuno-blotted with a TRPV1 
antibody, confirming the presence of TRPV1 receptors in these cat 
esophageal epithelial cells. Adapted from Cheng et al.
72
mune cells, with special emphasis on eosinophils.
38 PAF is 
among the most important inducers of eosinophil function and 
evokes the release of reactive oxygen species by immune cells
39,40 
and by esophageal circular muscle.
41,42
PAF levels increased in the HCl-filled mucosal sac and in its 
supernatant when compared to controls (Krebs filled mucosal sac 
at pH 7.4) (Fig. 5). The HCl-induced increase in PAF was abol-
ished by the TRPV1 receptor antagonist IRTX but not by neural 
block with tetrodotoxin, indicating that production of PAF may 
arise from non-neural pathways, and most likely from the esoph-
ageal epithelium. TRPV1 receptors are present in non-neural 
cells, such as keratinocytes of the epidermis,
43,44 in the human 
keratinocyte cell line HaCaT,
43 in the human bronchial epithelial 
cell line BEAS-2B,
21 in bladder urothelium and smooth mus-
cle,
45,46 liver,
47 polymorphonuclear granulocytes
48 and macro-
phages.
49  
5. TRPV1 receptors are present in epithelial cells
The presence of TRPV1 receptor mRNA in esophageal mu-
cosa was shown by reverse transcriptase-polymerase chain re-
action (RT-PCR) (Fig. 6A). In feline keratinocytes enzymati-
cally isolated and sorted by flow cytometry to a purity of 
90%-95%  RT-PCR confirms the presence of TRPV1 receptor 
mRNA (Fig. 6A). Western blot analysis confirms the presence of 
TRPV1 protein in epithelial cells purified with an epithelial cell 
selective pan-cytokeratin antibody (Fig. 6B).
50-55Inflammatory Mediators in Esophageal Mucosa
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Figure 8. Contraction of esophageal circular muscle (Control) in 
response to electrical field stimulation (EFS) is almost abolished by 
supernatant of capsaicin-filled mucosal sac (MCS). The reduction is 
reversed by application of the transient receptor potential channel 
vanilloid subfamily member-1 (TRPV1) antagonist 5’-iodoresinfer-
ratoxin (IRTX, 10
-5 M) inside the mucosal sac (MCS + IRTX), 
confirming presence of TRPV1 vanilloid receptors in the mucosal 
wall.  The reduction is also reversed by pre-exposure of the muscle to 
the platelet activating factor (PAF) receptor antagonist CV3988 
(MCS + CV3988 [10
-6 M]). This is consistent with release of PAF 
by mucosa in response to activation of TRPV1 by capsaicin, and 
suggests that PAF may be the inflammatory mediator most re-
sponsible for impairment of EFS-induced (ie, neurally-induced) 
contraction of circular muscle. Adapted from Cheng et al.
72
Figure 9. HCl-induced activation of transient receptor potential 
channel vanilloid subfamily member-1 (TRPV1) receptors in eso-
phageal mucosa results in neurally-mediated release of substance P 
(SP) and calcitonin gene related peptide (CGRP), and non-neurally 
mediated release of platelet activating factor (PAF) from epithelial 
cells.
Figure 7. Contraction of esophageal circular muscle (Control) in 
response to electrical field stimulation (EFS) is almost abolished by 
supernatant of HCl-filled mucosal sac (MHS). The reduction is 
reversed by application of the transient receptor potential channel 
vanilloid subfamily member-1 (TRPV1) antagonist 5’-iodoresinfer-
ratoxin (IRTX, 10
-5 M) inside the mucosal sac (MHS + IRTX), 
confirming presence of TRPV1 vanilloid receptors in the mucosal 
wall.  Adapted from Cheng et al.
72
Production of PAF in esophageal epithelial cells, in response 
to TRPV1 activation has been confirmed in the human esoph-
ageal epithelial cell line HET-1A, where the sequential steps be-
ginning with TRPV1 receptor activation and resulting in PAF 
production has been elucidated.
56
6. TRPV1 receptor activation in the esophageal mucosa 
inhibits esophageal contraction
HCl-induced activation of TRPV1 receptors, affects con-
traction of esophageal circular muscle as electric field stimulation 
(EFS)-induced contraction of esophageal circular strips was al-
most abolished by incubation in the supernatant of the HCl-filled 
mucosal sac (Fig. 7). This supernatant-induced inhibition was 
reduced when the TRPV1 antagonist IRTX was present inside 
the mucosal sac, confirming the contribution of functional cap-
saicin-sensitive TRPV1 receptors in the mucosal wall.
When TRPV1 is activated by the selective TRPV1 agonist 
capsaicin, the reduction in contraction caused by the sac super-
natant is almost abolished by pre-exposure the TRPV1 antago-
nist IRTX, confirming a role of TRPV1 in this effect. The con-
traction is restored by the PAF receptor antagonist CV9388 (Fig. 
8). This is consistent with release of PAF by epithelial cells in re-
sponse to activation of TRPV1 by capsaicin and indicates that 
PAF is a major inflammatory mediator affecting circular muscle 
contraction.
We conclude that HCl-induced activation of TRPV1 re-
ceptors in esophageal epithelial cells results in neurally mediated 
release of SP and CGRP, and non-neurally mediated release of 
PAF from the epithelium (Fig. 9).Karen M Harnett, et al
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Figure 11. (A) When mucosa was exposed to HCl (pH 4.0, 3 hours), IL-6 did not significantly increase in the mucosa or in the supernatant 
surrounding the mucosal sac when compared to normal Krebs-treated mucosa (control) samples. (B) When mucosa was exposed to HCl, IL-1β 
increased significantly in the mucosa (paired t test, *p < 0.05) but not in the supernatant surrounding the mucosal sac. IL-6 and IL-1β levels were 
measured by enzyme immunoassay. Means ± SEM are shown for 3 esophagus samples. Adapted from Cheng et al.
41
Figure 10. Direct application of HCl (pH 4.0, 3 hours) to circular 
muscle strips (Muscle + HCl) did not change contraction in 
response to electrical field stimulation (supramaximal voltage, 0.2 
ms), when compared to untreated muscle (Muscle). Supernatant of 
HCl-filled mucosa (HCl-MS, pH 4.0, 3 hours), however, almost 
abolished the contraction (p < 0.05, ANOVA for comparison of 
HCl-MS to Muscle + HCl) The supernatant-induced inhibition 
was reversed when the competitive platelet activating factor (PAF) 
antagonist CV3988 (10
-6 M) was added to the supernatant of the 
HCl-filled mucosal sac (CV3988 + HCl-MS) (p < 0.05, ANOVA 
for comparison of CV3988 + HCl-MS to HCl-MS). Means ±
SEM are shown for 3 esophagus samples. Modified from Cheng et 
al.
41
7. TRPV1-induced release of inflammatory mediators in 
the human esophagus
Similarly to the cat, contraction of human esophageal circular 
muscle is affected by the inflammatory mediators released by the 
mucosa, rather than by diffusion of HCl through the mucosal 
barrier, because when human esophageal circular muscle is di-
rectly exposed to HCl (pH 4, 2-3 hours) no change in EFS-in-
duced contraction occurs (Fig. 10). When the mucosal sac is fil-
led with HCl at the same pH, however, its supernatant almost 
abolishes contraction in response to EFS and the inhibition is 
suppressed by PAF antagonists. This finding is confirmed by di-
rect measurements of PAF that, similarly to the cat, is released in 
response to HCl in the esophageal lumen. It is of interest to note 
that the acid-filled mucosa does not increase production of IL-6 
(Fig. 11) and that, although production of IL-1 is increased in 
the mucosa, IL-1 is not released in the supernatant surrounding 
the mucosal sac (Fig. 11). These data point to PAF as a major in-
flammatory mediator released by epithelial cells to affect circular 
muscle contraction.
41 PAF inhibits neurally mediated contraction 
by inhibiting release of acetylcholine from cholinergic neurons 
(Fig. 12). 
The HCl-filled mucosal sac releases PAF into the super-
natant
41 and addition of a PAF receptor antagonist essentially 
abolished the supernatant-induced inhibition of neurally-medi-
ated circular muscle contraction (Fig. 10). This indicates that 
PAF is a major mucosa-derived mediator depressing muscle 
contraction.
41 PAF can also activate the esophageal circular mus-
cle to secrete IL-6.
41 The muscle-derived IL-6 then leads to en-
hanced production of H2O2, which in turn induces the secretion Inflammatory Mediators in Esophageal Mucosa
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Figure 12. (A) Incubation of normal esophageal smooth muscle strips in the platelet activating factor (PAF) analog PAF-16 (10
-5 M, 1-2 hours) 
almost abolished contraction in response to electrical field stimulation (EFS) (p < 0.05, ANOVA). (B) EFS-induced release of acetylcholine 
(ACh) from esophageal circular muscle strips is shown as control. Incubation of normal muscle strips in PAF-16 (10
-5 M, 1-2 hours) reduced ACh 
release to basal levels (p < 0.05, ANOVA for comparison of PAF-16 to control), suggesting that PAF inhibits EFS-induced contraction by 
inhibiting release of ACh. Means ± SEM are shown for 3 esophagus samples. Adapted from Cheng et al.
41
Figure 13. In the circular muscle platelet activating factor (PAF), 
released by the mucosa causes production of IL-6, that, in turn 
activates the enzyme nicotinamide adenine dinucleotide phosphate 
(NADPH) oxidase, inducing production of H2O2 and IL-1β that, 
in turn, induce production of PAF by the circular muscle. PAF is 
only partly produced by IL-1β, because the IL-1β antibody partly 
reduced PAF formation. The data suggest that H2O2 may induce 
formation of PAF directly, and in part through formation of IL-1β 
(see reference 2 for details). Adapted from Cheng et al.
41
of IL-1.
41,42 H2O2 and IL-1 can themselves induce PAF pro-
duction (Fig. 13). This indicates the existence of a self-perpetuat-
ing cycle of inflammation and motility abnormalities that is start-
ed by HCl-induced PAF release from the esophageal mucosa.
PAF, IL-1 and IL-6 can independently alter neurogenic 
esophageal muscle contraction, mostly by inhibiting release of 
acetylcholine.
8,57 
8. Role of epithelium in HCl-induced inflammation
This mucosal sac model contains a variety of different cell 
types, including epithelial, mesenchymal, neural, etc, that may 
contribute to the inflammatory process. As epithelial cells, how-
ever, have first contact with acid they may play a critical role in the 
early pathophysiological events leading to GERD. The esoph-
ageal epithelium is embryologically, morphologically and func-
tionally related to the skin epithelium, which is recognized as a 
major immunological organ.
58 Esophageal keratinocytes most 
likely serve as the initiating cell type in esophageal inflammation 
by expressing activation and cell adhesion molecules and by se-
creting a variety of proinflammatory cytokines that affect leuko-
cyte recruitment and activity.
59
9. Chemoattractants and activators of peripheral blood 
leukocytes
In addition to affecting circular muscle contraction, PAF in-
duces production of H2O2 in leukocytes (preferentially in eosino-
phils)
60 and is among the most important inducers of eosinophil 
function. It is a potent chemoattractant for eosinophils and se-
lectively induces the migration of eosinophils over neutro-
phils.
38,61 PAF has an important role in eosinophil transmigration Karen M Harnett, et al
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Figure 14. Peripheral blood leukocyte (PBL) migration was 
examined using a dual chamber motility system, where the upper 
chamber was separated from the lower chamber by a Polycarbonate 
track-etch  membrane with 3 μm pores. Cell migration was allowed to 
proceed from the upper to the lower chamber for 60 minutes at 37
oC 
in a CO2 incubator. The lower chamber contained materials to be 
tested for their effect on PBL motility. PBL motility was measured 
with an ATP Luminescence-Based Motility-Invasion assay. PBL 
migration (60 minutes at 37ºC) was significantly increased by IL-8 
(0.5 × 10
-9 M), as expected, and by the supernatant of the HCl (pH 
5.0, 3 hours)-filled mucosal sac (*p < 0.05, ANOVA). When using 
antagonists or antibodies, cells were pretreated with the anta-
gonist/antibody for 30 minutes before being placed in the upper 
chamber. The lower chamber contained the same concentration of 
antagonists or antibodies as the upper chamber. The increased PBL 
migration was significantly reduced by IL-8 immuno-neutralization 
by an IL-8 antibody (1:200), by a platelet activating factor receptor 
antagonist (CV3988, 10
-5 M) and by an neurokinin-1 receptor 
(NK-1R) antagonist (10
-5 M) (**p < 0.05, ANOVA). The in-
creased PBL migration was not affected by a calcitonin gene related 
peptide antagonist (CGRP-[8-37], 10
-6 M). Data represent mean
± SEM of 3 experiments. Adapted from Ma et al.
77a
through basement membrane components,
62 it promotes actin 
polymerization
63 and eosinophil adherence to vascular endothelial 
cells
64 and evokes the release of  reactive oxygen species.
39,40
Several studies have reported that in experimental animal 
models and in human reflux esophagitis, pro-inflammatory cyto-
kine production may underlie the development of erosive esoph-
agitis,
8-12 which is defined by the infiltration of neutrophils and 
eosinophils into the submucosa. However, the mechanisms 
whereby acid exposure and PAF lead to the recruitment of im-
mune cells in the esophageal mucosa are not known.
Several factors have been suggested as being chemotactic for 
neutrophils and eosinophils. IL-8, a CXC chemokine with potent 
chemotactic activity for neutrophils, is elevated in the esophageal 
mucosa of esophagitis patients,
11,65 suggesting a possible role of 
IL-8 in the pathogenesis of erosive esophagitis induced by acid 
reflux. SP is known to be a chemoattractant and activator of lym-
phocytes, monocytes, mast cells and importantly neutrophils and 
eosinophils.
66
We propose that acid in the lumen of the esophagus activates 
TRPV1 receptors causing the production and release of PAF, SP 
and CGRP that, in turn, may attract and activate immune cells 
contributing to inflammation and injury of the esophageal 
mucosa.  
The rabbit has been used extensively
67-71 as a model for the 
study of the human esophageal mucosa. Rabbit esophageal mu-
cosa, similarly to cat,
72 contains TRPV1 receptors and responds 
to HCl by producing SP, CGRP and PAF. In addition the rab-
bit esophageal mucosa produces IL-8, that is known to be ele-
vated in GERD and to attract leukocytes, particularly neutro-
phils.
73-77
To understand the inflammatory process in the esophagus it 
is important to establish which inflammatory mediators are re-
leased by HCl-stimulated esophageal mucosa at concentrations 
sufficient to attract and activate peripheral blood leukocytes. 
Rabbit esophageal mucosa has been used for these experiments. 
Peripheral blood leukocytes (PBL) were used to examine cell mi-
gration in response to the inflammatory mediators/chemokines 
present in the supernatant of the HCl-stimulated mucosal sac. 
PBL migration in response to IL-8 and to mucosal supernatant 
has been examined by using a migration chamber. Figure 14 shows 
that IL-8 induces PBL migration. PBL migration induced by su-
pernatant of HCl-treated mucosa was comparable to that induced 
by IL-8. Selective antagonists were used to assess the individual 
contribution of inflammatory mediators present in the supernatant. 
The figure shows that a selective CGRP antagonist did not affect 
PBL migration. In contrast, a selective IL-8 antibody, a PAF re-
ceptor antagonist, and an neurokinin-1 receptor antagonist (ie, SP 
antagonist) significantly reduced PBL migration, supporting a role 
of IL-8, PAF and SP as relevant chemokines.
Activated polymorphonuclear leukocytes (including neu-
trophils, basophils and eosinophils) have been used as the proto-
type of cells which vigorously produce superoxide anions
78 which, 
in turn, generate other reactive oxygen species (ROS) together 
with microbiocidal peptides and proteases. ROS comprise species 
such as superoxide, H2O2, nitric oxide and hydroxyl radicals.
79 
These highly reactive molecules are known to regulate many im-Inflammatory Mediators in Esophageal Mucosa
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Figure 15. To examine the effect of mucosal supernatant on H2O2 
production, peripheral blood leukocyte (PBL) were incubated for 20 
minutes at 37ºC in mucosal supernatant from sac incubated in Krebs 
buffer alone (control) or in acidified Krebs buffer (pH 5.0, 3 hours) 
(supernatant).  The supernatant of the acidified mucosal sac caused a 
2-fold increase in H2O2 production by PBL (*p < 0.05, ANOVA). 
When using antagonists or antibodies, PBL were pretreated with the 
antagonist/antibody for 30 minutes before exposure to the super-
natant. The increase in H2O2 levels was not affected by a calcitonin 
gene related peptide antagonist (CGRP-[8-37], 10
-6 M) or by IL-8 
immuno-neutralization by an IL-8 antibody (1:200). The increased 
H2O2 levels, however, were significantly reduced by a platelet ac-
tivating factor receptor antagonist (CV3988, 10
-5 M) and by an 
neurokinin-1 receptor (NK-1R) antagonist (10
-5 M) (**p < 0.05, 
ANOVA). Data represent mean ± SEM of 8 experiments. Adapted 
from Ma et al.
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Figure 16. An esophageal specimen 
obtained from an organ donor exhi-
bited hyperemia of the mucosa with 
scattered hemorrhagic erosions in the 
lower esophagus, extending across the 
cardia. (A) Gross finging shows ero-
sions, basal zone hyperplasia and elon-
gation of lamina propria papillae with 
congestion. The enlarged area (B) shows 
inflammatory cells present in the epi-
thelial layer. These findings are charac-
teristic of reflux esophagitis. Modified 
from Cheng et al.
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portant cellular events, including gene expression,
80 transcription 
factor activation,
81 DNA synthesis
82 and cellular proliferation.
83 
The enzymes nicotinamide adenine dinucleotide phosphate oxi-
dase (NOX) and dual oxidase generate ROS in a regulated man-
ner, producing reactive oxygen in cells and tissues in response to 
growth factors, cytokines and calcium signals.
84
While activated PBL produce inflammatory products other 
than H2O2, H2O2 may be used as a model for PBL-derived ROS 
because H2O2 is physiologically produced in large amounts by 
cells such as granulocytes, is relatively stable and has been widely 
used to assess the effects of ROS.
79
H2O2 levels, taken as measure of PBL activation, increased 
when PBL are exposed to sac supernatant at pH 5 (Fig. 15). The 
contribution of the individual mediators to PBL activation may 
be assessed by using the appropriate antagonists. The increase 
was not affected by a CGRP antagonist or by IL-8 neutralization, 
suggesting that neither CGRP nor IL-8, at the concentrations 
present in the supernatant, play a role in inducing H2O2 pro-
duction by PBL. In contrast, a PAF antagonist and a neuro-
kinin-1 receptor antagonist (ie, SP antagonist) significantly re-
duce supernatant-induced H2O2 production.
Thus the inflammatory mediators produced by HCl ex-
posure may act as chemokines, as immune cells activators, or 
both. In our system, IL-8 acts only as a chemokine, substance P 
and PAF act as both chemokines and activators, CGRP, does 
neither. The data suggest that PBL migration and H2O2 pro-
duction may be different functions, possibly depending on differ-
ent signal transduction pathways.Karen M Harnett, et al
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Figure 18. Lower esophageal sphincter (LES) circular muscle was examined by reverse transcriptase-polymerase chain reaction (RT-PCR) for 
the presence of nicotinamide adenine dinucleotide phosphate (NADPH) oxidases. We used published primers for NOX1-NOX5, and found that 
these components of the NADPH oxidase enzyme are all present in esophageal circular muscle, but only NOX5 mRNA was increased in the human 
specimen with esophagitis, as shown in (A). Increased NOX5 cDNA in the esophagitis specimen was confirmed by real-time RT-PCR, when 
compared to normal human esophageal circular muscle, as shown in (B). Means ± SEM are shown for 3 normal (control) and for 3 IL-1β-treated 
LES samples. Modified from Cheng et al.
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Figure 17. Circular muscle strips were mounted in muscle cham-
bers, stretched to 2.5 g to bring them near conditions of optimum 
force development, and equilibrated for 4-6 hours while perfused 
continuously with oxygenated physiologic salt solution at 37ºC. 
During this time the tension in lower esophageal sphincter (LES) 
strips increased, attaining a steady level at 3-4 hours. In LES circular 
muscle strips from the esophagitis specimen obtained from an organ 
donor, tone was lower than in normal strips. H2O2 treatment of 
muscle strips from the esophagitis specimen with the scavenger 
catalase (800 U/mL) for 30 min significantly increased LES tone, 
almost to a normal level. These data indicate that H2O2 may be 
responsible for the reduced tone in esophagitis. Means ± SEM are 
shown for 3 normal LES samples. Modified from Cheng et al.
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These results, derived from an ex vivo model mimicking re-
flux-induced events in vivo, identifies the type and quantity of in-
flammatory mediators likely produced in GERD. Since cellular 
immune infiltrate is a prerequisite for severe inflammation and 
tissue damage, inhibition of IL-8, SP and PAF-induced PBL 
migration and activation may provide potential targets for 
therapy.
Chronic Esophagitis: Role of Platelet
  Activating Factor and
  Hydrogen Peroxide
The previous data were obtained in normal human and ani-
mal esophageal specimens after short (3 hours) exposure of 
esophageal mucosa to acid, and short (3 hours) exposure of circu-
lar muscle to mucosa supernatant. To examine whether the data 
may also be applicable to chronic esophagitis, we refer to a human 
organ donor specimen with histologically demonstrated erosive 
esophagitis (Fig. 16).
85 In this specimen, the circular muscle was 
taken from the lower esophageal sphincter (LES). Essentially the 
same inflammatory processes are present in the body of the 
esophagus and in the LES. This is not surprising as the in-
flammation begins with damage to the epithelial cells in the mu-
cosa, that are not different from epithelial cells in the body of the 
esophagus.
When mounted in a warm (37
oC) oygenated muscle cham-
ber, normal-LES circular muscle strips gradually develop tone 
and reach a steady state tone after 3-4 hours. In contrast, circular 
muscle strips from esophagitis LES develop little tone, falling Inflammatory Mediators in Esophageal Mucosa
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Figure 20. Esophagitis and H2O2 increase platelet activating factor 
(PAF) production in lower esophageal sphincter (LES). The PAF 
concentration was quantified by using a 
3[H] PAF scintillation 
proximity assay system (Amersham Pharmacia Biotech Inc, Prin-
ceton, NJ, USA). In esophagitis circular muscle PAF levels were 
four times higher than in normal LES. In normal LES muscle, PAF 
levels were significantly increased (*p ＜ 0.01, unpaired t test) by 
H2O2 (70 mM, 2 hours). Modified from Cheng et al.
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Figure 21. The data suggest that exposure of esophageal mucosa to 
acid activates transient receptor potential channel vanilloid subfamily 
member-1 receptors, inducing neurally-mediated formation of sub-
stance P (SP) and calcitonin gene related peptide and production of 
platelet activating factor (PAF), IL-8 and probably other cytokines 
by the epithelium. SP, PAF and IL-8 behave as chemoattactants for 
peripheral blood leukocytes. In addition, SP and PAF activate im-
mune cells to produce H2O2. In the circular muscle layer, PAF alone 
is sufficient to almost completely inhibit release of acetylcholine 
(ACh) from cholinergic neurons, thus inhibiting esophageal circular 
muscle contraction. In addition, PAF induces sequential production 
of IL-6, H2O2, IL-1β and PAF in the circular muscle, all con-
tributing to reduction of esophageal contraction and esophageal 
sphincter tone. TRPV1, transient receptor potential channel va-
nilloid subfamily member-1; CGRP, calcitonin gene related peptide; 
PBL, peripheral blood leukocyte; NADPH, nicotinamide adenine 
dinucleotide phosphate.
Figure 19. Esophagitis increases H2O2 treatment of muscle strips 
from the esophagitis specimen with the  levels in lower esophageal 
sphincter (LES) circular smooth muscle, as measured by a color-
imetric assay. H2O2 levels were 4-fold higher in LES muscle from 
the esophagitis specimen compared with normal muscle. Means ±
SEM are shown for 3 normal LES samples. Modified from Cheng 
et al.
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outside of the normal tone minus 2 standard deviations. When 
circular muscle strips from the esophagitis LES were exposed to 
the H2O2 scavenger catalase, tone increased and reached a value 
similar to that of strips from normal LES (Fig. 17). These find-
ings suggest that H2O2 may be present in circular muscle of 
esophagitis LES, and responsible for reduced tone when in-
flammation is present. 
Upregulation of NOXs is a possible mechanism for over-
production of H2O2. The NOXs present in human esophageal 
circular muscle, and possibly upregulated by esophagitis were ex-
amined by RT-PCR. Whereas NOX1-NOX5 are all present in 
esophageal circular muscle, only NOX5 mRNA was increased in 
the human specimen with esophagitis, as shown in Figure 18A. 
Increased NOX5 mRNA in the esophagitis specimen was con-
firmed by real-time RT-PCR, when compared to normal human 
esophageal circular muscle, as shown in Figure 18B.
Figure 19 shows H2O2 levels in normal and esophagitis cir-
cular muscle tissue. Basal H2O2 levels were elevated in circular 
muscle of esophagitis LES, exceeding normal levels by more than 
2 standard deviations.
PAF levels were elevated in the circular muscle of the human 
esophagitis sample and exceeded those of the normal sample by 
more than 2 standard deviations (Fig. 20). Incubation of normal 
LES circular muscle in H2O2 (70 M, 2 hours) significantly in-
creased PAF levels (p ＜ 0.01). Karen M Harnett, et al
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Conclusion
Epithelial cells, not only constitute the first barrier to dif-
fusion of refluxate, but are important participants in inflam-
mation as they respond to HCl-mediated activation of TRPV1 by 
releasing cytokines and inflammatory mediators. Cytokines and 
inflammatory mediators may diffuse to the circular muscle layer 
affecting contraction and may attract and activate immune cells. 
PAF and IL-8 produced by epithelial cells, together with SP re-
leased from submucosal neurons attract peripheral blood leuko-
cytes, that are activated by both PAF and SP to produce H2O2. 
H2O2 is uncharged, freely diffusible through cellular mem-
branes, and likely to interact with membrane lipids, causing lipid 
peroxidation and peroxidation-induced inflammatory mediators. 
H2O2 may contribute to further production of PAF and cause 
upregulation of NOX in the mucosa and muscle. H2O2 may also 
interact with DNA bases (more than 20 different oxidatively al-
tered purines and pyrimidines have been detected and charac-
terized),
86 perhaps inducing alterations of cell phenotype and 
possibly resulting in permanent mutations. The data are summar-
ized in Figure 21.
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